← all drugs
Everolimus Tablet
being discontinued · Transplant · Snapshot: 2026-08-25
- Manufacturers listed
- Teva Pharmaceuticals USA, Inc., Endo Pharmaceuticals, Inc., Mylan Pharmaceuticals Inc., a Viatris Company
- Machine-readable
- JSON for this drug
Presentations (11)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Everolimus, Tablet, 2.5 mg (NDC 0093-7766-24) | Teva Pharmaceuticals USA, Inc. | unknown | 03/02/2026 |
| Everolimus, Tablet, 2.5 mg (NDC 49884-119-91) | Endo Pharmaceuticals, Inc. | unknown | 01/06/2026 |
| Everolimus, Tablet, 2 mg (NDC 0378-0005-85) | Mylan Pharmaceuticals Inc., a Viatris Company | unknown | 11/03/2025 |
| Everolimus, Tablet, 3 mg (NDC 0378-0006-85) | Mylan Pharmaceuticals Inc., a Viatris Company | unknown | 11/03/2025 |
| Everolimus, Tablet, 10 mg (NDC 49884-128-91) | Endo Pharmaceuticals, Inc. | unknown | 01/06/2026 |
| Everolimus, Tablet, 10 mg (NDC 0093-7769-24) | Teva Pharmaceuticals USA, Inc. | unknown | 03/02/2026 |
| Everolimus, Tablet, 5 mg (NDC 49884-125-91) | Endo Pharmaceuticals, Inc. | unknown | 01/06/2026 |
| Everolimus, Tablet, 5 mg (NDC 0378-0007-85) | Mylan Pharmaceuticals Inc., a Viatris Company | unknown | 11/03/2025 |
| Everolimus, Tablet, 7.5 mg (NDC 49884-127-91) | Endo Pharmaceuticals, Inc. | unknown | 01/06/2026 |
| Everolimus, Tablet, 5 mg (NDC 0093-7767-24) | Teva Pharmaceuticals USA, Inc. | unknown | 03/02/2026 |
| Everolimus, Tablet, 7.5 mg (NDC 0093-7768-24) | Teva Pharmaceuticals USA, Inc. | unknown | 03/02/2026 |
History
Daily change tracking began 2026-08-25 (index founding). Status flips and availability changes will accumulate here.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.